A new trading day began on Friday, with Teladoc Health Inc (NYSE: TDOC) stock price down -5.49% from the previous day of trading, before settling in for the closing price of $8.56. TDOC’s price has ranged from $6.76 to $15.43 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 41.76%. Meanwhile, its annual earnings per share averaged 83.91%. With a float of $171.88 million, this company’s outstanding shares have now reached $173.41 million.
Considering the fact that the conglomerate employs 5500 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 63.2%, operating margin of -8.52%, and the pretax margin is -38.67%.
Teladoc Health Inc (TDOC) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Health Information Services Industry. The insider ownership of Teladoc Health Inc is 1.03%, while institutional ownership is 73.74%. The most recent insider transaction that took place on Mar 20 ’25, was worth 173,416. In this transaction CHIEF FINANCIAL OFFICER of this company sold 20,586 shares at a rate of $8.42, taking the stock ownership to the 116,309 shares. Before that another transaction happened on Mar 20 ’25, when Company’s CHIEF LEGAL OFFICER, SECRETARY sold 11,011 for $8.42, making the entire transaction worth $92,757. This insider now owns 64,308 shares in total.
Teladoc Health Inc (TDOC) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 83.91% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 49.20% during the next five years compared to -33.66% drop over the previous five years of trading.
Teladoc Health Inc (NYSE: TDOC) Trading Performance Indicators
Here are Teladoc Health Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.69. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.55. Likewise, its price to free cash flow for the trailing twelve months is 4.97.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.88, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -0.85 in one year’s time.
Technical Analysis of Teladoc Health Inc (TDOC)
Compared to the last year’s volume of 7.67 million, its volume of 4.17 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 51.15%. Additionally, its Average True Range was 0.57.
During the past 100 days, Teladoc Health Inc’s (TDOC) raw stochastic average was set at 2.06%, which indicates a significant decrease from 11.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.23% in the past 14 days, which was lower than the 70.39% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.24, while its 200-day Moving Average is $9.38. Nevertheless, the first resistance level for the watch stands at $8.38 in the near term. At $8.67, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.82. If the price goes on to break the first support level at $7.93, it is likely to go to the next support level at $7.78. Should the price break the second support level, the third support level stands at $7.49.
Teladoc Health Inc (NYSE: TDOC) Key Stats
With a market capitalization of 1.41 billion, the company has a total of 173,672K Shares Outstanding. Currently, annual sales are 2,570 M while annual income is -1,001 M. The company’s previous quarter sales were 640,490 K while its latest quarter income was -48,410 K.
